Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Arthritis Rheum. 2009 Aug;60(8):2480–2489. doi: 10.1002/art.24684

Table 5.

Association between digital loss, digital ischemia, eRVSP and mortality and the presence of anti-B2GPI and anti-centromere antibodies.

ACA +
(n=78)		 ACA and
B2GPI+
(n = 29)		 ACA+ only
(n = 49)		 ACA and B2GPI+
vs.
ACA+ only
  Outcome % (n) OR (95% CI)§ % % OR (95% CI)§
Digital Loss 60 (47) 3.28 (1.4, 7.7) 66 (19) 57 (28) 1.5 (0.5, 4.8)
Digital Ischemia 35 (27) 1.15 (0.3, 3.9) 59 (17) 20 (10) 16.4 (3.4, 80.5)
High eRVSP 42 (33) 1.3 (0.4, 3.8) 69 (20) 27 (13) 7.9 (2.6, 24.4)
Mortality 28 (22) 0.4 (0.1, 1.3) 39 (11) 22 (10) 2.9 (1.1, 10.1)
§

ORs for digital loss were estimated using conditional logistic regression. ORs for digital ischemia, eRVSP and mortality were estimated using logistic regression adjusting for age, gender, race, disease type, digital loss and smoking status. ACA = anti-centromere antibodies